Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies

• Published in: International journal of dermatology Vol. 55; no. 5; pp. e295 - e304
• Main Authors: Lai, Yi C., Yew, Yik W., Schwartz, Robert A.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.05.2016
• Subjects: Cholesterol, HDL - blood; Comorbidity; Dyslipidemias - blood; Dyslipidemias - epidemiology; Humans; Lichen Planus - blood; Lichen Planus - epidemiology; Lipoproteins, LDL - blood; Observational Studies as Topic; Triglycerides - blood
• ISSN: 0011-9059; 1365-4632; 1365-4632
• DOI: 10.1111/ijd.13234

Background Lichen planus (LP) is a chronic inflammatory disease that has been shown to be positively associated with dyslipidemia. However, the magnitude and types of the underlying lipid abnormalities have not been investigated. This study aims to conduct a systematic review and meta‐analysis to investigate the qualitative and quantitative association between LP and dyslipidemia. Methods A systematic search of studies published from inception to April 1, 2015, was conducted using MEDLINE, EMBASE, Web of Science, and Cochrane library databases. Meta‐analyses of observational studies with both categorical and continuous outcome were performed. DerSimonian and Lard random effects models were utilized to calculate the pooled odds ratio and weighted mean difference (WMD). Publication bias was evaluated by funnel plot and Egger's test. Results Seven studies with 5242 subjects were included in this meta‐analysis. Patients with LP were significantly more likely to have dyslipidemia, with a pooled odds ratio of 1.74 (95% confidence interval [CI]: 1.19–2.54, P = 0.004). LP was associated with higher levels of triglycerides (WMD 83.37 mg/dl, 95% CI 0.62–166.12, P = 0.048), low‐density lipoprotein (18.75 mg/dl, 95% CI −17.21 to 54.72, P = 0.307), total cholesterol (19.22 mg/dl, 95% CI −8.80 to 47.25, P = 0.179), and lower levels of high‐density lipoprotein cholesterol (−8.96 mg/dl, 95% CI −21.22 to 3.30, P = 0.152). Conclusions Despite considerable heterogeneity, this study demonstrated that LP was significantly associated with an increased risk of dyslipidemia and higher triglyceride levels. For patients presenting with LP, physicians should be cognizant of this association and consider screening them for dyslipidemia.